C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study

Por Iwasa, Ryota, Yamada, Akihiro, Sono, Koji, Furukawa, Ryuichi, Takeuchi, Ken, Suzuki, Yasuo
Publicado no BMC Gastroenterol (2015)

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis

Por Yoshimatsu, Yasushi, Yamada, Akihiro, Furukawa, Ryuichi, Sono, Koji, Osamura, Aisaku, Nakamura, Kentaro, Aoki, Hiroshi, Tsuda, Yukiko, Hosoe, Nobuo, Takada, Nobuo, Suzuki, Yasuo
Publicado no World J Gastroenterol (2015)